These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32830304)

  • 1. Home Therapies in Advanced Heart Failure: Inotropes and Diuretics.
    Graffagnino JP; Avant LC; Calkins BC; Swetz KM
    Curr Heart Fail Rep; 2020 Oct; 17(5):314-323. PubMed ID: 32830304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
    López-Candales AL; Carron C; Schwartz J
    Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Inotrope Therapy: A Narrative Review.
    Chuzi S; Allen LA; Dunlay SM; Warraich HJ
    JAMA Cardiol; 2019 Aug; 4(8):815-822. PubMed ID: 31268467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory Inotrope Infusions in Advanced Heart Failure: A Systematic Review and Meta-Analysis.
    Nizamic T; Murad MH; Allen LA; McIlvennan CK; Wordingham SE; Matlock DD; Dunlay SM
    JACC Heart Fail; 2018 Sep; 6(9):757-767. PubMed ID: 30007556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond diuretics: management of volume overload in acute heart failure syndromes.
    Hill JA; Yancy CW; Abraham WT
    Am J Med; 2006 Dec; 119(12 Suppl 1):S37-44. PubMed ID: 17113399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care.
    Tomasoni D; Vishram-Nielsen JKK; Pagnesi M; Adamo M; Lombardi CM; Gustafsson F; Metra M
    ESC Heart Fail; 2022 Jun; 9(3):1507-1523. PubMed ID: 35352499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Home Inotropes and Other Palliative Care.
    Ginwalla M
    Heart Fail Clin; 2016 Jul; 12(3):437-48. PubMed ID: 27371519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Inotropes on Patient-Reported Health Status in End-Stage Heart Failure: A Review of Published Clinical Trials.
    Clarke JD; Riello R; Allen LA; Psotka MA; Teerlink JR; Lindenfeld J; Desai NR; Ahmad T
    Circ Heart Fail; 2021 Feb; 14(2):e007759. PubMed ID: 33530705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Intravenous Inotropic Support for Advanced Heart Failure: Palliative Considerations.
    McPherson A; Nguyen C; Groninger H; Anderson KM; Henderson P; Rao A
    J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):59-67. PubMed ID: 35319327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure.
    Hershberger RE; Nauman D; Walker TL; Dutton D; Burgess D
    J Card Fail; 2003 Jun; 9(3):180-7. PubMed ID: 12815567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inotropic therapy for heart failure: an evidence-based approach.
    Felker GM; O'Connor CM
    Am Heart J; 2001 Sep; 142(3):393-401. PubMed ID: 11526351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute decompensated heart failure: best evidence and current practice.
    Mehta R; Feldman D
    Minerva Cardioangiol; 2005 Dec; 53(6):537-47. PubMed ID: 16333237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of decompensated heart failure.
    Branum K
    AACN Clin Issues; 2003 Nov; 14(4):498-511; quiz 551-3. PubMed ID: 14595209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
    Martens P; Vercammen J; Ceyssens W; Jacobs L; Luwel E; Van Aerde H; Potargent P; Renaers M; Dupont M; Mullens W
    ESC Heart Fail; 2018 Aug; 5(4):562-569. PubMed ID: 29341466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Status of Inotropes in Heart Failure.
    Ginwalla M; Tofovic DS
    Heart Fail Clin; 2018 Oct; 14(4):601-616. PubMed ID: 30266368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of positive inotropes in end-of-life heart failure care.
    Nauman DJ; Hershberger RE
    Curr Heart Fail Rep; 2007 Sep; 4(3):158-63. PubMed ID: 17883992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration.
    Oliva F; Perna E; Marini M; Nassiacos D; Cirò A; Malfatto G; Morandi F; Caico I; Perna G; Meloni S; Vincenzi A; Villani A; Vecchi AL; Minoia C; Verde A; De Maria R;
    Int J Cardiol; 2018 Dec; 272():255-259. PubMed ID: 30131229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials.
    Ahmad T; Miller PE; McCullough M; Desai NR; Riello R; Psotka M; Böhm M; Allen LA; Teerlink JR; Rosano GMC; Lindenfeld J
    Eur J Heart Fail; 2019 Sep; 21(9):1064-1078. PubMed ID: 31407860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.